Log in Sign up
1 Matching Annotations
  1. Aug 2022
  2. www.medrxiv.org www.medrxiv.org
    https://medrxiv.org/cgi/content/10.1101/2022.02.15.22270948
    1
    1. jackiekrauss 29 Aug 2022
      in BehSci

      Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948

      is:preprint lang:en COVID-19 Omicron immunogenicity efficacy safety mRNA vaccine fourth dose clinical intervention symptomatic disease healthcare worker breakthrough infection high viral load antibody titer next generation vaccine development
    Visit annotations in context

    Tags

    • next generation vaccine development
    • fourth dose
    • high viral load
    • healthcare worker
    • immunogenicity
    • antibody titer
    • safety
    • symptomatic disease
    • efficacy
    • mRNA vaccine
    • lang:en
    • COVID-19
    • clinical intervention
    • is:preprint
    • Omicron
    • breakthrough infection

    Annotators

    • jackiekrauss

    URL

    medrxiv.org/content/10.1101/2022.02.15.22270948v1.full.pdf
Share:
Group. Only group members will be able to view this annotation.
Only me. No one else will be able to view this annotation.
Hypothes.is
  • About
  • Blog
  • Bioscience
  • Education
  • Jobs
  • Help
  • Contact
  • Terms of Service
  • Privacy Policy